Contact Information for GDC-0077 & HormoneTherapy with or without Ibrance for Advanced Breast Cancer
The sites for this trial are listed below.
If you speak with a site, please mention that you were referred by BreastCancerTrials.org
Massachusetts General Hospital.,
Boston,
MA,
02114
Contact person: |
Reference Study ID Number: ... |
Phone: | 888-662-6728 (U.S. and ... |
Email: |
global-roche-genentech-trials@gene.com |
Dana Farber Cancer Institute,
Boston,
MA,
02215
Contact person: |
Reference Study ID Number: ... |
Phone: | 888-662-6728 (U.S. and ... |
Email: |
global-roche-genentech-trials@gene.com |
Columbia University Medical Center,
New York,
NY,
10032
Contact person: |
Reference Study ID Number: ... |
Phone: | 888-662-6728 (U.S. and ... |
Email: |
global-roche-genentech-trials@gene.com |
Memorial Sloan Kettering Cancer Center,
New York,
NY,
10065
Contact person: |
Reference Study ID Number: ... |
Phone: | 888-662-6728 (U.S. and ... |
Email: |
global-roche-genentech-trials@gene.com |
Sarah Cannon Research Institute,
Nashville,
TN,
37203
Contact person: |
Reference Study ID Number: ... |
Phone: | 888-662-6728 (U.S. and ... |
Email: |
global-roche-genentech-trials@gene.com |